Immuron (IMRN) Exchange Rate Effect (2016 - 2024)
Immuron (IMRN) recorded quarterly Exchange Rate Effect of $39482.6 in Q4 2024, up 183.31% quarter-over-quarter from -$47394.7 in Q4 2023, and up 183.31% on a YoY basis from $13936.4 in Q1 2024.
Immuron (IMRN) Exchange Rate Effect (2016 - 2024) Analysis & Trends
Immuron's Exchange Rate Effect history runs 9 years deep, the most recent figure standing at $39482.6 for Q4 2024.
- In Q4 2024, Exchange Rate Effect rose 183.31% year-over-year to $39482.6; the TTM figure through Dec 2024 stood at -$535877.9 (up 57.87% YoY), while the FY2025 annual figure was $10825.0, down 78.04% from the prior year.
- Exchange Rate Effect was $39482.6 for Q4 2024 at Immuron, up from -$47394.7 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $39482.6 in Q4 2024 to a low of -$696559.0 in Q4 2020.
- Historically, Exchange Rate Effect has averaged -$246487.4 across 5 years, with a median of -$47394.7 in 2023.
- The sharpest annual moves came in 2020 and 2024: Exchange Rate Effect tumbled 3238.36% in 2020, then jumped 183.31% in 2024.
- A 5-year view of Exchange Rate Effect shows it stood at -$696559.0 in 2020, then increased by 26.8% to -$509893.8 in 2021, then soared by 96.46% to -$18072.0 in 2022, then slumped by 162.25% to -$47394.7 in 2023, then surged by 183.31% to $39482.6 in 2024.
- The last three Exchange Rate Effect figures came in at $39482.6 (Q4 2024), -$47394.7 (Q4 2023), and -$18072.0 (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 39,482.63 |
| Dec 31, 2024 | 39,482.63 |
| Dec 31, 2023 | -47,394.71 |
| Dec 31, 2023 | -47,394.71 |
| Dec 31, 2022 | -18,072.00 |
| Dec 31, 2022 | -18,072.00 |
| Dec 31, 2021 | -509,893.78 |
| Dec 31, 2021 | -509,893.78 |
| Dec 31, 2020 | -696,559.00 |
| Dec 31, 2020 | -696,559.00 |
| Dec 31, 2019 | 22,195.00 |
| Dec 31, 2019 | 22,195.00 |
| Dec 31, 2018 | -112,270.00 |
| Dec 31, 2018 | -112,270.00 |
| Dec 31, 2017 | 22,040.59 |
| Dec 31, 2017 | 22,040.59 |
| Dec 31, 2016 | 110.83 |
| Dec 31, 2016 | 110.83 |